BDBM50140057 2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3,4-diol5-(6-Amino-purin-9-yl)-2-methyl-tetrahydro-furan-3-ol::5-(6-Amino-purin-9-yl)-2-methyl-tetrahydro-furan-3-ol::CHEMBL282503
SMILES: CC1OC(CC1O)n1cnc2c(N)ncnc12
InChI Key: InChIKey=FFHPXOJTVQDVMO-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenylate cyclase type V (Rattus norvegicus) | BDBM50140057 (2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetra...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases Curated by ChEMBL | Assay Description Compound was evaluated for inhibition of adenylate cyclase from rat brain | J Med Chem 47: 1207-13 (2004) Article DOI: 10.1021/jm0303599 BindingDB Entry DOI: 10.7270/Q2Q52QC7 | |||||||||||
More data for this Ligand-Target Pair |